SCHEMBL12428430

SCHEMBL12428430

NC(=O)C1=NN(c2ccccc2)C(=O)/C1=C\c1ccc(-c2ccc3c(c2)CCCN3c2ccccc2)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 2/20 0.42
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EP300 Q09472 2/20 0.36
HDAC6 Q9UBN7 1/20 0.36
OPRM1 P35372 8/20 0.35
OPRK1 P41145 8/20 0.35
OPRD1 P41143 7/20 0.35
ACHE P22303 1/20 0.35
PRF1 P14222 3/20 0.35
CREBBP Q92793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12428249 0.90 EP300 (0.41) SCN9AKDM4EMEN1ALDH1A1LMNA
SCHEMBL12428451 0.89 SCN9A (0.38) SCN9AKDM4EMEN1ALDH1A1LMNA
SCHEMBL12428264 0.88 EP300 (0.40) SCN9AKDM4EMEN1ALDH1A1LMNA
SCHEMBL12428261 0.88 EP300 (0.40) SCN9AKDM4EMEN1ALDH1A1LMNA
SCHEMBL12428432 0.86 KAT8 (0.45) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL12428436 0.84 MEN1 (0.48) SCN9AKDM4EMEN1ALDH1A1LMNA
SCHEMBL12428429 0.83 PTPN22 (0.43) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL12428435 0.82 KMT2A (0.36) SCN9AKDM4EMEN1ALDH1A1LMNA
SCHEMBL12428242 0.80 EP300 (0.37) KDM4EMEN1ALDH1A1LMNAMAPT
SCHEMBL12428273 0.80 SCN9A (0.36) SCN9AKDM4EMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-7977570-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-07-12 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
US-20090084441-A1 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-04-02 US disclosed
EP-1885015-A1 DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE Nippon Kayaku Kabushiki Kaisha (JP) 2008-02-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090084441-A1 Dye-sensitized photoelectric conversion device CRY1, H1-5, H1-0 SCN9A 175/4885KDM4E 314/4885MEN1 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.